Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Vismodegib> ?p ?o. }
Showing items 1 to 71 of
71
with 100 items per page.
- Vismodegib abstract "Vismodegib (trade name Erivedge) is a drug for the treatment of basal-cell carcinoma (BCC). The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. The drug is also undergoing clinical trials for metastatic colorectal cancer, small-cell lung cancer, advanced stomach cancer, pancreatic cancer, medulloblastoma and chondrosarcoma as of June 2011. The drug was developed by the biotechnology / pharmaceutical company Genentech, which is headquartered at South San Francisco, California, USA.".
- Vismodegib atcPrefix "L01".
- Vismodegib atcSuffix "XX43".
- Vismodegib bioavailability "31.8".
- Vismodegib casNumber "879085-55-9".
- Vismodegib chEBI "66903".
- Vismodegib drugbank "DB08828".
- Vismodegib fdaUniiCode "25X868M3DS".
- Vismodegib iupacName "2-Chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide".
- Vismodegib pubchem "24776445".
- Vismodegib thumbnail Vismodegib2DACS.svg?width=300.
- Vismodegib wikiPageID "32314428".
- Vismodegib wikiPageRevisionID "595715512".
- Vismodegib atcPrefix "L01".
- Vismodegib atcSuffix "XX43".
- Vismodegib bioavailability "31.8".
- Vismodegib c "19".
- Vismodegib casNumber "879085".
- Vismodegib chebi "66903".
- Vismodegib chembl "473417".
- Vismodegib chemspiderid "23337846".
- Vismodegib cl "2".
- Vismodegib drugbank "DB08828".
- Vismodegib eliminationHalfLife "1036800.0".
- Vismodegib eliminationHalfLife "345600.0".
- Vismodegib excretion "Faeces , urine".
- Vismodegib h "14".
- Vismodegib hasPhotoCollection Vismodegib.
- Vismodegib image "Vismodegib3Dan.gif".
- Vismodegib iupacName "2".
- Vismodegib legalAu "S4".
- Vismodegib legalCa "Rx-only".
- Vismodegib legalUk "POM".
- Vismodegib legalUs "Rx-only".
- Vismodegib licenceEu "Erivedge".
- Vismodegib licenceUs "Vismodegib".
- Vismodegib metabolism "<2% metabolised by CYP2C9, CYP3A4, CYP3A5".
- Vismodegib molecularWeight "421.3".
- Vismodegib n "2".
- Vismodegib o "3".
- Vismodegib pregnancyAu "X".
- Vismodegib pregnancyUs "D".
- Vismodegib proteinBound "> 99%".
- Vismodegib pubchem "24776445".
- Vismodegib routesOfAdministration "Oral".
- Vismodegib s "1".
- Vismodegib smiles "CSC1=CCCl".
- Vismodegib stdinchi "1".
- Vismodegib stdinchikey "BPQMGSKTAYIVFO-UHFFFAOYSA-N".
- Vismodegib synonyms "GDC-0449, RG-3616".
- Vismodegib tradename "Erivedge".
- Vismodegib unii "25".
- Vismodegib subject Category:Benzanilides.
- Vismodegib subject Category:Organochlorides.
- Vismodegib subject Category:Sulfones.
- Vismodegib type Drug.
- Vismodegib type FunctionalSubstance.
- Vismodegib comment "Vismodegib (trade name Erivedge) is a drug for the treatment of basal-cell carcinoma (BCC). The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. The drug is also undergoing clinical trials for metastatic colorectal cancer, small-cell lung cancer, advanced stomach cancer, pancreatic cancer, medulloblastoma and chondrosarcoma as of June 2011.".
- Vismodegib label "Vismodegib".
- Vismodegib label "Vismodegib".
- Vismodegib label "Vismodégib".
- Vismodegib label "ビスモデギブ".
- Vismodegib sameAs Vismodegib.
- Vismodegib sameAs Vismodégib.
- Vismodegib sameAs ビスモデギブ.
- Vismodegib sameAs m.0gyvnyj.
- Vismodegib sameAs Q2070286.
- Vismodegib sameAs Q2070286.
- Vismodegib wasDerivedFrom Vismodegib?oldid=595715512.
- Vismodegib depiction Vismodegib2DACS.svg.
- Vismodegib isPrimaryTopicOf Vismodegib.
